I reported previously (see here) on Israel’s Intec Pharma which is developing treatments based on its innovative Accordion technology. Intec’s COO Nadav Navon provided an update of Intec’s pipeline on ILTV. Phase 3 trials have now commenced on Intec’s Parkinson’s treatment.
Treatment for advanced Parkinson’s disease
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.